Dianthus Therapeutics, Inc. · NASDAQ:DNTH

Deep Track Capital, LP reported a 7.34% stake in Dianthus Therapeutics, Inc. (Schedule 13G)

Event Mar 17, 2025 · Filed Mar 24, 2025

Deep Track Capital, LP reported a 7.34% stake in Dianthus Therapeutics, Inc., 2,357,702 shares, as a passive investor on Mar 17, 2025. Filed Mar 24, 2025 (Schedule 13G).

Stake
7.34%
Shares
2,357,702
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Deep Track Capital, LP7.34%2,357,702
Deep Track Biotechnology Master Fund, Ltd.7.34%2,357,702
David Kroin7.34%2,357,702

Source

View original at SEC

Related